Back Pain |
Back Injuries; Pain, Back |
Clinical Trial: Combined Interventions for Treating Depression and Chronic Back Pain
This study is currently recruiting patients.
Verified by National Institute of Mental Health (NIMH) September 2005
|
Purpose
| Condition | Intervention |
|---|---|
| Back Pain Depression | Behavior: Cognitive behavioral therapy Drug: Antidepressants Behavior: Problem solving therapy |
MedlinePlus related topics: Back Pain; Depression
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Efficacy Study
Official Title: Integrated Care for Depression and Chronic Back Pain
Expected Total Enrollment: 100
Study start: October 2004; Expected completion: July 2006
The relationship between depression and back pain is complex. Depression is the most common mental condition associated with chronic back pain. Despite this relationship, many patients with depression and back pain seek treatment only for one of the two conditions, which can worsen the untreated condition. An intervention that reduces the symptoms of both depression and back pain is needed. This study will determine the effectiveness of an integrated intervention in reducing both back pain and depression symptoms.
Participants will be randomly assigned to receive either an integrated intervention or standard of care for 6 months. Participants in the integrated intervention group will receive cognitive behavioral therapy for back pain and antidepressants and/or problem solving therapy for depression. Study visits will initially occur once a week and then taper to once every 2 weeks for the 6-month duration; the time of tapering will depend on participant response to treatment and will be at the investigator’s discretion. Depression and back pain symptoms will be assessed in all participants at study entry, at the end of treatment, and 6 months after the end of treatment. The study entry and study completion assessments will occur during study visits. The last assessment will be a telephone interview.
Eligibility
Inclusion Criteria:
- Roland back pain score of 7 or greater
- Diagnosis of major depression
- Plan to stay enrolled in Group Health Cooperative for the duration of the study and 1 year after the study
Exclusion Criteria:
Location and Contact Information
Washington
Group Health Cooperative, Seattle, Washington, 98101, United States; Recruiting
Benjamin Balderson, PhD 206-287-2803 balderson.b@ghc.org
Michael R. VonKorff, ScD, Principal Investigator
Benjamin Balderson, PhD, Sub-Investigator
Elizabeth H.B. Lin, MD, MPH, Sub-Investigator
Michael R. VonKorff, ScD, Principal Investigator, Group Health Cooperative
More Information
Last Updated: September 10, 2005
Record first received: September 7, 2005
ClinicalTrials.gov Identifier: NCT00158275
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-09-13

Not Signed In -


